• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Vu Q&A Page 2

Vu Q&A

August 8, 2023

Diana Padilla on the Intersection of Opioids and Hepatitis C

August 8, 2023

Tessa Bialek and Dr. Matthew J. Akiyama on Expanding Hepatitis C Testing and Treatment in Prisons and Jails

Read More

April 13, 2023

Developing a Continuum of Care (Care Cascade) for Hepatitis C

Read More

November 16, 2022

Suzanne Davies on Managed Care Organizations and Medicaid

Read More

October 27, 2022

Dr. Mark Sulkowski on Relationship Between Viral Hepatitis, HIV & Liver Cancers

Read More

October 24, 2022

Dr. Heather Bradley and Boatemaa Ntiri-Reid on the Inaugural Viral Hepatitis Surveillance Report

Read More

August 11, 2022

Chari Cohen On The Importance Of Vaccinating Against Hepatitis B

Read More

July 28, 2022

HepVu’s One Question Series on Viral Hepatitis Elimination: People Who Inject Drugs

Read More

May 18, 2022

HepVu’s One Question Series on Viral Hepatitis Elimination: Testing

Read More

May 12, 2022

Dr. Rita Isabel Lechuga on National Hispanic Hepatitis Awareness Day

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.